Supplier Type
- Manufacturer
- Reagent
- Trader
- custom synthesis
- contract manufacturer
Supplier Region
- Bangalore(3)
- Gujarat(26)
- Hyderabad(38)
- New Delhi(5)
- Mumbai(51)
- Andhra Pradesh(4)
- Beijing(2)
- Maharashtra(27)
- Delhi(12)
- Karnataka(9)
- Ahmedabad(10)
- Vadodara(15)
- Kolkata(3)
- Pune(5)
- Tamil Nadu(3)
- Telangana(4)
- Haryana(2)
- Uttar Pradesh(4)
- Madhya Pradesh(1)
- GOA(1)
- Nagpur(1)
- Punjab(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- Pure
- Powder 99%
- Paste 70%
- NLT 95%
- NLT 90.00%
- NLT 90%
- N/A
- more than 95%
- more than 90%
- MIN 99.5%
- Min 98.0%
- Min 98. 00%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Liquid 28%
- Greater than 99%
- Empagliflozin intermediate, Dapagliflozin Impurity
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- 99.99%
- 99.98%
- 99.95%
- 99.91%
- 99.9% min
- 99.86%
- 99.85%
- 99.80%
- 99.73%
- 99.65%
- 99.56%
- 99.50%
- 99.5%
- 99.42%
- 99.29%
- 99.21%
- 99.20%
- 99.05%
- 99.00%
- 99%+
- 99% HPLC
- > 99%
- 99%
- >99%
- >99 %
- 99 %
- 99
- 98+
- 98.99%
- 98.9%
- 98.70%
- 98.68%
- 98.60%
- 98.12%
- 98.00%
- 98%+
- 98% Min
- 98% +
- 98%
- > 98%
- 98 - 99 %
- 97-99%
- 97.57%
- 97.25%
- 97.20%
- 97.18%
- 97.00%
- 97%
- >97%
- 97 %
- 96-98%
- 96.80%
- 96.56%
- 96.39%
- 96.20%
- 96.14%
- 96%
- 95.48%
- 95.00%
- 95%
- >95%
- 94.00%
- 93%
- >92%
- 90%
- >90%
- 90 % Above
- 70%
- 4%/8% & 1.6M
- 3.0M
- 2.85-3.5m
- 2.0M
- 15%
- 100%
- 1.0M/3.0M/ 3.2M
- 1.0M/2.0M/ 2.9M/3.0M
- 1.0M/2.0M
- 1.0M
- 0.7M in
- 0.5M/2.0M/ 2.8M
- 0.5M/1.0M/ 3.0M/3.4M
- 0.5M
- 0.25M
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1g
- 1gm
- 5g
- 10g
- 25g
- 50g
- 100ml
- 100g
- 100gm
- 500g
- 500ml
- 1kg
- 1L
- 5kg
- 10kg
- 25kg
- 50kg
- 500kg
- 1MT
- 1and gm
- 250250 mg.
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 100kg
-
(3R,4S)-4-(4-(Benzyloxy)Phenyl)-1-(4-Fluorophenyl)-3-((S)-3-(4- Fluorophenyl)-3-Hydroxypropyl)Azetidin-2-One
163222-32-0
-
2H-Pyran-3-carboxamide, N,6-bis(4-fluorophenyl)tetrahydro-2-(4-hydroxyphenyl)-
1050631-82-7
-
Ezetimibe Benzyl Diol Impurity
1374250-06-2
-
Benzyl chloride
100-44-7
-
2-(5-BroMo-2-Methylbenzyl)-5-(4-fluorophenyl)thiophene
1030825-20-7
-
2-Methoxyethyl acetate
110-49-6
-
3,5-Dimethoxytoluene
4179-19-5
-
(3r,4r)-1-benzyl-4-hydroxy-3-pyrrolidinemethanol
253129-03-2
-
Methyl eugenol
93-15-2
-
Tetradecyldimethylbenzylammonium chloride
139-08-2
Ezetimibe Benzyl Ether Impurity 163222-32-0
EZETIMIBE CYCLIC ETHER IMPURITY 1050631-82-7
>95% Ezetimibe Benzyl Diol Impurity, 25mg, Industrial Grade 1374250-06-2
Benzyl chloride 100-44-7
2-(5-Bromo-2-methyl-benzyl)-5-(4-fluoro-phenyl)-thiophene 1030825-20-7
Ethyleneglycol monomethyl ether acetate 110-49-6
5-Methylresorcinol dimethyl ether 4179-19-5
(3R,4R)-1-Benzyl-4-hydroxy-3-pyrrolidinemethanol 253129-03-2
Eugenyl methyl ether 93-15-2
N-Benzyl-N,N-dimethyl-N-tetradecylammonium chloride 139-08-2